5656 related articles for article (PubMed ID: 306870)
21. Recall skin-test antigens and the prognosis of stage I melanoma.
Aranha GV; McKhann CF; Simmons RL; Grage TB
J Surg Oncol; 1979; 11(1):13-6. PubMed ID: 431077
[TBL] [Abstract][Full Text] [Related]
22. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
23. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
Gupta S; Seth SK; Udupa KN; Sen PC
Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
[TBL] [Abstract][Full Text] [Related]
24. Immunocompetence, immunodeficiency and prognosis in cancer.
Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
[TBL] [Abstract][Full Text] [Related]
25. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
[TBL] [Abstract][Full Text] [Related]
26. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
Gutterman J; Mavligit G; McBride C; Frei E; Hersh EM
Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915
[No Abstract] [Full Text] [Related]
27. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
Das SN; Khanna NN; Khanna S
Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
[TBL] [Abstract][Full Text] [Related]
28. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
29. Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
Mavligit GM; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1976 Oct; 57(4):749-51. PubMed ID: 1003526
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Germeraad WT; Kishida T; Ueda E; Takenaka H; Mazda O; Kishimoto S
J Dermatol Sci; 2009 Jan; 53(1):40-7. PubMed ID: 18804963
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy for melanoma.
Vaisrub S
JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440
[No Abstract] [Full Text] [Related]
32. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
Moertel CG; Ritts RE; Schutt AJ; Hahn RG
Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
[TBL] [Abstract][Full Text] [Related]
33. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Remy W; Dorn R; Ulm K; Mayerhausen W
Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immune competence in patients with prostatic carcinoma.
Stefani SS; Menon M; Canning JR; Clark SS
J Urol; 1978 Oct; 120(4):431-4. PubMed ID: 702665
[TBL] [Abstract][Full Text] [Related]
35. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
Das SN; Khanna NN; Khanna S
Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
[TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
Alsabti EA
Oncology; 1979; 36(4):171-5. PubMed ID: 157453
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
38. [Immunologic response in patients with melanoma of the skin].
Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
[TBL] [Abstract][Full Text] [Related]
39. Selective immunological evaluation of mycosis fungoides.
Cooperrider PA; Roenigk HH
Arch Dermatol; 1978 Feb; 114(2):207-12. PubMed ID: 629547
[TBL] [Abstract][Full Text] [Related]
40. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
Gersten MJ; Hadden EM; Kaplan MH; Pinsky CM; Armstrong D; Hadden JW
Clin Bull; 1977; 7(2):63-9. PubMed ID: 902403
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]